Cancer

BIOCRATES Participates in 2.9 Million Euro EU Cancer Diagnostics Project

Published in Cancer Weekly, May 22nd, 2007

BIOCRATES life sciences will play a pivotal role in one of the latest framework six EU projects called COBRED. COBRED's participants will use innovative technology platforms to find diagnostic biomarkers for two of the most common cancers, Colon and Breast Cancer.

Each partner brings specific strengths to the project, creating a strong R&D collaboration. Biocrates' strengths lie in targeted metabolomics. Brad Morie, Chief Business Development Officer at Biocrates, said "This project comes at a perfect time for us. We have officially launched our proprietary targeted metabolomics services platform, TargetIDQ(TM). TargetIDQ(TM) has proven effective in our collaborations...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-05-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry